Viewing Study NCT00622505


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-03-06 @ 8:05 AM
Study NCT ID: NCT00622505
Status: COMPLETED
Last Update Posted: 2021-05-26
First Post: 2008-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple myeloma View
None zoledronic acid View
None skeletal complications View
None bone View